The Chinese contract research organization (CRO) GemPharmatech continues to incr...
Click Therapeutics has secured a notable regulatory milestone with the U.S. Food...
In a continued series of strategic moves, VelaVigo Bio, a biotechnology firm bas...
Biolinq has announced the successful closure of a $100 million venture capital i...
Roche, the drugmaker giant, announced its interest in investing $50 billion over...
Johnson & Johnson MedTech successfully conducted the initial clinical use of Ott...
Bristol Myers Squibb disclosed that its drug stavartanate did not successfully i...
Merck & Co. is taking a significant step toward transforming its peptide therapi...
Sanofi’s ambition to become a dominant force in immunology continues to take sha...
Eli Lilly’s oral GLP-1 receptor agonist orforglipron has met its primary efficac...
GSK has received regulatory approval in the United Kingdom for two new combinati...
Vanda Pharmaceuticals is pushing back against the U.S. Food and Drug Administrat...
Pfizer said that it had discovered a possible instance of medication-induced liv...
US-based biotechnology company Rallybio is discontinuing its RLYB212 program for...
The U.S. may soon impose significant tariffs on pharmaceutical imports, accordin...
Through its licensing deal with Eli Lilly, Sangamo Therapeutics received $18 mil...
